Monosacáridos

D-sorbose is a diastereomer of D-xylose. It inhibits the glycolysis pathway, which stops the production of energy and leads to cell death. D-sorbose is synthesized from D-xylose by enzymatic conversion with 1,4-dihydroxybenzene. The crystalline form of D-sorbose is polymorphic and can be identified using X-ray diffraction. It has been shown to have cytotoxic effects on C. elegans and A. actinomycetes, but not on E. coli or other Gram negative bacteria. The imbalance in the ratio of these organisms may lead to an increased risk for cancer in humans.

D-Galacturonic acid benzyl ester is a donor of d-galacturonic acid that is used to regulate the growth of bacterial cells. It has been shown to be an acceptor for oligosaccharides, which are substrates for glycosidases. D-Galacturonic acid benzyl ester has been shown to have anti-inflammatory effects in animal models and may be useful in the treatment of heart diseases, such as cardiac hypertrophy.

5-Keto-D-gluconic acid is an intermediate in the synthetic pathway of glucose. The enzyme 5-keto-D-gluconate dehydrogenase catalyzes the conversion of 5-keto-D-gluconate to D-glucono-1,5-lactone. This reaction is important for plant physiology and is used industrially for the production of citric acid. In order to synthesize 5-keto-D-gluconic acid, a p. pastoris strain was engineered with an increased expression of 5KGDH, which led to an increase in the production of this compound. This synthesis took place through a dinucleotide phosphate intermediate that was formed by two molecules of malonic acid. Citric acid was also synthesized from this intermediate.
The enzyme activity levels were measured using a bacterial strain that contained a wild type gene sequence (WT) and a mutant gene sequence (

Conduritol D (CD) is a natural product that has been isolated from the pancreas of rats. It is homochiral, and it has been shown to be active in the treatment of diabetic patients. CD has a hydroxy group at C-4' and an alcohol group at C-5'. The functional groups are acetylated at C-3', which may make this compound more potent than other similar compounds with different functional groups. It is also synthesized stereoselectively, making it a selective molecule. CD has been shown to have pharmacokinetic properties that may be beneficial for treating diabetes.

D-Glucarate monopotassium is a pharmaceutical preparation that is used to inhibit the growth of bacteria. It inhibits the proliferation of cells by inhibiting fatty acid synthesis, which leads to decreased levels of cholesterol, and reduces the uptake of glucose. D-Glucarate monopotassium is also an oxidizing agent that converts uridine into uric acid and has been shown to have inhibitory properties against human cancer cells. D-Glucarate monopotassium can be used as an antioxidant for the prevention or treatment of chronic diseases such as atherosclerosis, diabetes, and cancer. This compound acts as an inhibitor for trypsin treatment on carbohydrates, preventing hydrolysis by this enzyme.

L-Glucurono-3,6-lactone is an acetonide that is a derivative of L-glucose. L-Glucurono-3,6-lactone can be used as a precursor for the synthesis of polyhydroxybutyrate (PHB).

D-Arabonic acid-1,4-lactone is a synthetic sugar that is modified to produce a variety of carbohydrates. This product can be used in the synthesis of oligosaccharides and monosaccharides. It is also used as a carbohydrate in the production of saccharide-based polymers, such as polysaccharides or polyols. This product has CAS number 2782-09-4 and a purity level of ≥99%.

4,6-O-Benzylidene-D-galactose is an anomer of D-galactose. It is a lectin that has been shown to inhibit the binding of amyloid beta to the cerebroside in the brain tissue. This activity may be due to its ability to form an amide bond with galactose, which is present in amyloid beta. 4,6-O-Benzylidene-D-galactose also has a coronary heart disease prevention effect and can help reduce cholesterol levels. Furthermore, it has been found to have anti-cancer properties and can help prevent the growth of cancerous cells by inhibiting protein synthesis. In addition, 4,6-O-Benzylidene-D-galactose can be used as a cationic surfactant or detergent composition for cleaning or treating surfaces.

Used to differentiate bacteria on the basis of carbohydrate fermentation abilities.

Methyl 2-deoxy-2-fluoro-a-D-mannopyranoside is a custom synthesis product. It is a fluorinated sugar that can be used in the modification of carbohydrates, saccharides, oligosaccharides, and polysaccharides. Methyl 2-deoxy-2-fluoro-a-D-mannopyranoside has shown to have high purity and excellent stability. This compound has been used for the synthesis of various saccharides including glucose, fructose, glycerol, erythritol, and mannitol.

Substrate for UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC)

2-Iodoethyl a-L-fucopyranoside is an organic compound that belongs to the group of fluorinated saccharides. It is used in the synthesis of oligosaccharides, polysaccharides, and complex carbohydrates. 2-Iodoethyl a-L-fucopyranoside can be modified with click chemistry at the C4 position for the synthesis of monosaccharides or sugar derivatives. This modification leads to high purity and chemical stability.

4-Aminophenyl b-D-lactopyranoside is a chemical compound that has been used to optimize the production of human immunoglobulin. It has been shown to have diagnostic value for several viruses, including Epstein-Barr virus and cytomegalovirus. Electron microscopic studies have revealed organisms agglutinated by 4-aminophenyl b-D-lactopyranoside. The receptor binding properties and antigen concentration of this compound have been determined using agglutinin and lectin techniques. This molecule also has inhibitory potency on the synthesis of polypeptides, which are essential for the growth of certain organisms.

The compound 1,4-dideoxy-1,4-imino-L-altritol is a synthetic carbohydrate that is made of a monosaccharide and an oligosaccharide. The monosaccharide is a simple sugar with the chemical formula C5H10O5. The oligosaccharide has the chemical formula C2n+1(C3H3O3)n. The monosaccharide has four carbons and one oxygen molecule. The oligosaccharide also has five carbon atoms, but it also has three oxygen molecules. The two sugars are linked by a glycosidic linkage.
The compound was created to be used in the synthesis of complex carbohydrates. It can be modified to have fluorine atoms added to it, methyl groups added to it, or both. It can also be modified to make it into an ester or an amide. It is soluble in water and alcohol

3,5-Di-O-lauryl-D-xylofuranose is a custom synthesized monosaccharide that is used as a raw material for the synthesis of complex carbohydrates. It has been modified with fluorine and methyl groups to produce 3,5-di-O-lauryl-D-xylofuranose. This compound can be used in the production of polysaccharides or saccharides. The chemical name for this compound is 3,5-di-O-[(9Z)-hexadecenyl]-2-(1E,3E)-dioxaheptalene.

N-2,4-Dinitrophenyl-deoxynojirimycin (DNPDNJ) is a methylated derivative of deoxynojirimycin. It is an inhibitor of glycosylation that can be used to study the structure and function of carbohydrates. DNPDNJ is a synthetic saccharide that can be custom synthesized. Click modification and modification with Oligosaccharides are common modifications for DNPDNJ. DNPDNJ is available in high purity and has been fluorinated for use in fluorescence studies.

Methyl 2-deoxy-D-ribofuranoside is a methylglucoside that is synthesized by the reaction of thiourea with chloroacetic acid. The anomers of this compound are atypical and the product can be obtained in high yield (70%) by the use of chromatographic purification. This chemical has been used to produce a variety of compounds including carbamates, chloroacetamides, sulfonamides and others. Methyl 2-deoxy-D-ribofuranoside is also an intermediate for asymmetric synthesis. It can act as a catalyst for reactions involving alkali metals and nucleophiles such as chloride, hydantoin and dimethylformamide. The structure of this molecule has been determined by nmr spectroscopy and its 1H NMR spectrum is consistent with that predicted from its molecular formula.

Fuculose is a monosaccharide that is a constituent of fucose-containing glycoproteins. It is found in the blood and urine, as well as in various tissues, such as liver, lung, kidney, and spleen. The biological properties of L-fuculose are related to its ability to form hydrogen bonds with other molecules. Fuculose has been shown to be an effective activator for cutaneous lesions in mice models. The structural analysis of L-fuculose has revealed that it contains a reactive site for the synthesis of glycosaminoglycans and polysaccharides. Fuculose has also been shown to increase the proliferation of some cells, including corynebacterium glutamicum and human umbilical vein endothelial cells (HUVECs). This property may be due to its ability to activate growth factors or interfere with cell signaling pathways.